New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
PROCEPT BioRobotics Corporation
PRCT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4B

Medical - Devices

Next Earning date - 25 Feb 2025

4B

Medical - Devices

Next Earning date - 25 Feb 2025

66.23USD

Shape0.23 ( 0.35%)
Market Closed (as of Feb 12, 21:00 EDT)
favorite-chart

Relative Strenght

33
favorite-chart

Volume Buzz

16%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated February 13, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

PRCT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$315M

Shape440%

2025-Revenue

$1.30

Shape-224%

2025-EPS

$297M

Shape-1507%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

105.00(58.54%)

Number of analyst

1

Last analyst upgrade/downgrade

Morgan Stanley

initialise

Previous: Not converted

2024-12-02

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.56
vs -0.42

Q1.23

arrow
arrow

N/A

-0.63
vs -0.39

Q2.23

arrow
arrow

N/A

-0.56
vs -0.43

Q3.23

arrow
arrow

N/A

-0.51
vs -0.51

Q4.23

arrow
arrow

N/A

-0.54
vs -0.56

Q1.24

arrow
arrow

N/A

-0.51
vs -0.63

Q2.24

arrow
arrow

N/A

-0.50
vs -0.56

Q3.24

arrow
arrow

N/A

-0.40
vs -0.51

Q4.24

arrow
arrow

N/A

-0.34
vs -0.54

Q1.25

arrow
arrow

N/A

-0.34
vs -0.51

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+135%

23.8M  vs 10.1M

Q1.23

arrow
arrow

+72%

24.4M  vs 14.2M

Q2.23

arrow
arrow

+98%

33.1M  vs 16.7M

Q3.23

arrow
arrow

+73%

35.1M  vs 20.3M

Q4.23

arrow
arrow

+83%

43.6M  vs 23.8M

Q1.24

arrow
arrow

+83%

44.5M  vs 24.4M

Q2.24

arrow
arrow

+61%

53.4M  vs 33.1M

Q3.24

arrow
arrow

+66%

58.4M  vs 35.1M

Q4.24

arrow
arrow

+53%

66.8M  vs 43.6M

Q1.25

arrow
arrow

+49%

66.2M  vs 44.5M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-16%

-0.16
vs -0.10

Q1.23

arrow
arrow

-16%

-0.16
vs -0.16

Q2.23

arrow
arrow

-16%

-0.16
vs -0.16

Q3.23

arrow
arrow

-8%

-0.08
vs -0.16

Q4.23

arrow
arrow

-10%

-0.10
vs -0.08

Q1.24

arrow
arrow

-10%

-0.10
vs -0.10

Q2.24

arrow
arrow

-10%

-0.10
vs -0.10

Q3.24

arrow
arrow

-9%

-0.09
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

118

118
vs 104

13%

Q1.23

arrow
arrow

120

120
vs 118

2%

Q2.23

arrow
arrow

128

128
vs 120

7%

Q3.23

arrow
arrow

131

131
vs 128

2%

Q4.23

arrow
arrow

151

151
vs 131

15%

Q1.24

arrow
arrow

171

171
vs 151

13%

Q2.24

arrow
arrow

210

210
vs 171

23%

Q3.24

arrow
arrow

265

265
vs 210

26%

Earnings Growth

Latest News